GLEN BURNIE, Md., June 5, 2017 /PRNewswire/ -- CSSi, the global leader in patient recruitment, enrollment, and retention solutions for the clinical research industry, will be exhibiting in booth #1951 at the upcoming 53rd Drug Information Association (DIA) Annual Meeting. During the event, CSSi will present demonstrations of its newest innovative technology offerings, SmartStudy ID and SmartConnect, to DIA 2017 attendees. The demonstrations will illustrate how these tools will transform the way sites and patients are selected, trials are enrolled, and patients are engaged.
"CSSi is thrilled to be a part of the DIA 2017 exhibitor lineup and have the opportunity to share our game-changing technologies with some of the industry's most notable thought leaders and potential customers," says Chris Trizna, President, CSSi. "For over 12 years, CSSi has been providing global patient recruitment and retention services directly to sites, CROs, and Sponsors. Our involvement with this event will allow us to continue our mission to exceed our customers' expectations by offering innovative solutions and outstanding services to enroll studies faster, in order to successfully get drugs and devices to patients in need."
SmartStudy ID and SmartConnect were developed with help from CSSi's in-house technology division, Nexus Informatics, to lessen the impact of recruitment and retention challenges within the rapidly-evolving industry. Making its debut at DIA 2017, SmartStudy ID will help identify qualified sites for a study based on a validated patient population data against protocol I/E criteria. CSSi's patient engagement portal, SmartConnect, was launched at DIA 2016 to help maintain patients' interest and enhance site-patient communication during a study. Both technologies will work hand-in-hand to positively impact the feasibility, patient recruitment, and retention of a study.
DIA 2017 is the largest, longest-running global interdisciplinary drug industry event that encourages innovation and supports the advancement of safe and effective medical products and therapies to patients. This year's event will bring together more than 7,000 life sciences professionals and feature more than 450 exhibiting companies, 11 tracks, 15 hot topics, and 160 sessions. The five-day event is scheduled to take place at the McCormick Place in Chicago, Illinois from June 18-22, 2017.
CSSi delivers global patient recruitment solutions to study sponsors, CROs, SMOs, and investigative sites that ensure successful enrollment on time, every time. Through its innovative enrollment planning and full-service patient recruitment solutions, CSSi is able to reduce the costs and timelines associated with recruitment of subjects for clinical studies. For more information on CSSi, please visit: www.CSSiEnroll.com, email: info@CSSiEnroll.com,="http://firstname.lastname@example.org." rel="nofollow" target="_blank">http://email@example.com. or call: (866) 277-4888.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cssi-to-showcase-latest-innovations-at-53rd-drug-information-association-annual-meeting-300468266.html